| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3250187
Max Phase: Preclinical
Molecular Formula: C26H42O2
Molecular Weight: 386.62
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: C=C1CC[C@H](O)C/C1=C\C=C1/CCC[C@]2(C)[C@@H]([C@H](C)CCC(C)(C)O)CC[C@@H]12
Standard InChI: InChI=1S/C26H42O2/c1-18-8-11-22(27)17-21(18)10-9-20-7-6-15-26(5)23(12-13-24(20)26)19(2)14-16-25(3,4)28/h9-10,19,22-24,27-28H,1,6-8,11-17H2,2-5H3/b20-9+,21-10+/t19-,22+,23-,24+,26-/m1/s1
Standard InChI Key: DEBFVLKHIKOBPN-QFNXGBIASA-N
Associated Targets(non-human)
Gallus gallus 1187 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 386.62 | Molecular Weight (Monoisotopic): 386.3185 | AlogP: 6.34 | #Rotatable Bonds: 5 |
| Polar Surface Area: 40.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
| #RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.21 | CX LogD: 5.21 |
| Aromatic Rings: 0 | Heavy Atoms: 28 | QED Weighted: 0.58 | Np Likeness Score: 2.76 |
References
| 1. Mouriño A, Blair P, Wecksler W, Johnson RL, Norman AW, Okamura WH.. (1978) Studies on vitamin D (calciferol) and its analogues. 15. 24-Nor-1alpha,25-dihydroxyvitamin D3 and 24-nor-25-hydroxy-5,6-trans-vitamin D3., 21 (10): [PMID:214553] [10.1021/jm00208a005] |
Source
Source(1):